____________________________
STELLAR and EU-MSC2
Symposia
September 11, STELLAR
08.30-09.00
Registration + Coffee
09.00-11.00
Keynote lectures
09.00-09.20
Building a translational (eco)system for regenerative medicine
Ton Rabelink
09.20-10-10
Challenges in nephrology: From prevention to precision medicine in
regenerative therapy
Giuseppe Remuzzi
10.10-11.00
Challenges in kidney regeneration: From kidney development to
organoids and the bioengineered kidney
Melissa Little
11.00-11.30
Networking break / Coffee-Tea
11.30-13.00
Mechanisms of Action of MSC
11.30-12.00
MoA: Insight in MSC and immune modulation
Francesco Dazzi
12.00-12.30
MoA: endocycling vs mitosis in kidney regeneration
Paola Romagnani
12.30-13.00
MoA: MSC and mitochondrial mobility
Marina Morigi
13.00-14.00
Networking break / Lunch
14.00-15.30
Implementation and
Exploitation of STELLAR results
14.00-14.30
Bioreactor development for cell therapy production
Ruud Das
14.30-15.00
GMP production process
Kathrin Godthardt
15.00-15.30
TopoWell plate controls the kidney MSC secretome
Jan de Boer
15.30-16.00
Networking break / Coffee-Tea
16.00-17.30
Clinical application and
economic benefits of MSC
16.00-16.30
Clinical use of MSC in kidney transplantation
Ton Rabelink
16.30-17.00
Clinical promise of
MSC in diabetic kidney disease
Matthew Griffin
17.00-17.30
Economic evaluation of MSC therapy in kidney disease
Wilbert vd Hout
17.30-18.15
Beyond STELLAR: the COLLAR
concept
Rutger Ploeg
19.00-23.00
Dinner at the Royal Museum of Antiquities
________________________________________________________________
September 12, EU-MSC2
08.30-09.00
Registration + Coffee
09.00-9.15
Welcome and opening
09.15-12.45
Presentation of Consortia
09.15-09.30
RETHRIM
Willem Fibbe
09.30-09.45
NEPHSTROM
Timothy O’Brien
09.45-10.00
ADIPOA-2
Frank Barry
10.00-10.15
AUTOSTEM
Mary Murphy
10.15-10.30
VISICORT
Matthew Griffin
10.30-10.45
SCIENCE
Jens Kastrup
10.45-11.15
Networking break / Coffee-Tea
11.15-11.30
BOOSTB4
Cecilia Götherström
11.30-11.45
SEPCELL
Olga de la Rosa
11.45-12.00
RESSTORE
Olivier Detante
12.00-12.15
REACH
Ruud Das
12.15-12.30
REDDSTAR
Steve Elliman
12-30-12.45
RESPINE
Christian Jorgensen
12.45-13.45
Networking Lunch break
13.45-15.45
Mechanisms of Action and
Potency Assays
13.45-14.00
MoA of MSC in GvHD
Koen Schepers
14.00-14.15
MoA of MSC in Kidney Regeneration
Paola Romagnani
14.15-14.30
MoA of MSC in Liver Disease
Yufang Shi
14.30-15.00
Mechanisms of Action and Potency assays: a regulatory perspective
Charlotte de Wolf
15.00-15.45
Round table discussion on MoA and Potency Assay Design
Expert Panel:
·
Francesco Dazzi
Moderators:
15.45-16.15
Networking break / Coffee-Tea
16.15-18.15
Interactive Product Development Discussion Session
Expert Panel:
Moderators:
16.15-16.45
MSC cell sorting vs.
PA bulk culture
Steve Elliman
16.45-17.15
Autologous vs.
Allogeneic MSC
Mary Murphy
17.15-17.45
Fresh vs. Frozen
Eleuterio Lombardo
17.45-18.15
FCS vs. PL vs.
Xenofree
Katarina le Blanc
19.00-22.00
Networking Walking
Dinner
September 13, EU-MSC2
09.00-13.00
Product development and Market Authorisation in a changing regulatory
landscape
09.00-09.30
Product development and
market authorisation, the helping hand of EMA
Ana Hildago-Simon
09.30-10.00
Stem cell medicine in
Australia: barriers to translation.
Melissa Little
10.00- 10.30
Ethical
considerations in a changing regulatory landscape
Kristina Hug
10.30-11.00
Designing research for maximum impact
Giovanni Migliaccio
11.00-11.30
Networking break /
Coffee-Tea
11.30-11.45
The phase III multicentre
non-VHP challenge
Liesbeth Oosten
11.45-12.00
VHP success story
Norberto Perico
12.00-12.15
VHP challenges
Jens Kastrup
12.15-13.00
Round table discussion on regulatory challenges
Expert panel
Moderators:
13.00
End of Meeting
____________________________
STELLAR and EU-MSC2
Symposia
September 11, STELLAR
08.30-09.00
|
Registration + Coffee
|
|
09.00-11.00
|
Keynote lectures
|
|
09.00-09.20
|
Building a translational (eco)system for regenerative medicine
|
Ton Rabelink
|
09.20-10-10
|
Challenges in nephrology: From prevention to precision medicine in
regenerative therapy
|
Giuseppe Remuzzi
|
10.10-11.00
|
Challenges in kidney regeneration: From kidney development to
organoids and the bioengineered kidney
|
Melissa Little
|
11.00-11.30
|
Networking break / Coffee-Tea
|
|
11.30-13.00
|
Mechanisms of Action of MSC
|
|
11.30-12.00
|
MoA: Insight in MSC and immune modulation
|
Francesco Dazzi
|
12.00-12.30
|
MoA: endocycling vs mitosis in kidney regeneration
|
Paola Romagnani
|
12.30-13.00
|
MoA: MSC and mitochondrial mobility
|
Marina Morigi
|
13.00-14.00
|
Networking break / Lunch
|
|
14.00-15.30
|
Implementation and
Exploitation of STELLAR results
|
|
14.00-14.30
|
Bioreactor development for cell therapy production
|
Ruud Das
|
14.30-15.00
|
GMP production process
|
Kathrin Godthardt
|
15.00-15.30
|
TopoWell plate controls the kidney MSC secretome
|
Jan de Boer
|
15.30-16.00
|
Networking break / Coffee-Tea
|
|
16.00-17.30
|
Clinical application and
economic benefits of MSC
|
|
16.00-16.30
|
Clinical use of MSC in kidney transplantation
|
Ton Rabelink
|
16.30-17.00
|
Clinical promise of
MSC in diabetic kidney disease
|
Matthew Griffin
|
17.00-17.30
|
Economic evaluation of MSC therapy in kidney disease
|
Wilbert vd Hout
|
17.30-18.15
|
Beyond STELLAR: the COLLAR
concept
|
Rutger Ploeg
|
19.00-23.00
|
Dinner at the Royal Museum of Antiquities
|
|
________________________________________________________________
September 12, EU-MSC2
08.30-09.00
|
Registration + Coffee
|
||
09.00-9.15
|
Welcome and opening
|
||
09.15-12.45
|
Presentation of Consortia
|
||
09.15-09.30
|
RETHRIM
|
Willem Fibbe
|
|
09.30-09.45
|
NEPHSTROM
|
Timothy O’Brien
|
|
09.45-10.00
|
ADIPOA-2
|
Frank Barry
|
|
10.00-10.15
|
AUTOSTEM
|
Mary Murphy
|
|
10.15-10.30
|
VISICORT
|
Matthew Griffin
|
|
10.30-10.45
|
SCIENCE
|
Jens Kastrup
|
|
10.45-11.15
|
Networking break / Coffee-Tea
|
||
11.15-11.30
|
BOOSTB4
|
Cecilia Götherström
|
|
11.30-11.45
|
SEPCELL
|
Olga de la Rosa
|
|
11.45-12.00
|
RESSTORE
|
Olivier Detante
|
|
12.00-12.15
|
REACH
|
Ruud Das
|
|
12.15-12.30
|
REDDSTAR
|
Steve Elliman
|
|
12-30-12.45
|
RESPINE
|
Christian Jorgensen
|
|
12.45-13.45
|
Networking Lunch break
|
||
13.45-15.45
|
Mechanisms of Action and
Potency Assays
|
||
13.45-14.00
|
MoA of MSC in GvHD
|
Koen Schepers
|
|
14.00-14.15
|
MoA of MSC in Kidney Regeneration
|
Paola Romagnani
|
|
14.15-14.30
|
MoA of MSC in Liver Disease
|
Yufang Shi
|
|
14.30-15.00
|
Mechanisms of Action and Potency assays: a regulatory perspective
|
Charlotte de Wolf
|
|
15.00-15.45
|
Round table discussion on MoA and Potency Assay Design
|
||
Expert Panel:
·
Francesco Dazzi
·
Ton Rabelink
·
Steve Elliman
· Marcel Hoefnagel
|
Moderators:
·
Christian Jorgensen
·
Melissa Little
|
||
15.45-16.15
|
Networking break / Coffee-Tea
|
||
16.15-18.15
|
Interactive Product Development Discussion Session
|
||
Expert Panel:
·
Frank Barry
·
Olga del la Rosa
·
Brent Rice
·
Phil Newsome
|
Moderators:
·
Tim O’Brien
·
Willem Fibbe
|
||
16.15-16.45
|
MSC cell sorting vs.
PA bulk culture
In tissue flasks or
bioreactors
|
Steve Elliman
Christian Jorgensen
|
|
16.45-17.15
|
Autologous vs.
Allogeneic MSC
|
Mary Murphy
Marlies Reinders
|
|
17.15-17.45
|
Fresh vs. Frozen
of low or high PDL
|
Eleuterio Lombardo
Cecilia Götherström
|
|
17.45-18.15
|
FCS vs. PL vs.
Xenofree
Stimulated or
unstimulated
|
Katarina le Blanc
Cristina Trento
|
|
19.00-22.00
|
Networking Walking
Dinner
|
||
September 13, EU-MSC2
09.00-13.00
|
Product development and Market Authorisation in a changing regulatory
landscape
|
||
09.00-09.30
|
Product development and
market authorisation, the helping hand of EMA
|
Ana Hildago-Simon
|
|
09.30-10.00
|
Stem cell medicine in
Australia: barriers to translation.
|
Melissa Little
|
|
10.00- 10.30
|
Ethical
considerations in a changing regulatory landscape
|
Kristina Hug
|
|
10.30-11.00
|
Designing research for maximum impact
|
Giovanni Migliaccio
|
|
11.00-11.30
|
Networking break /
Coffee-Tea
|
||
11.30-11.45
|
The phase III multicentre
non-VHP challenge
|
Liesbeth Oosten
|
|
11.45-12.00
|
VHP success story
|
Norberto Perico
|
|
12.00-12.15
|
VHP challenges
|
Jens Kastrup
|
|
12.15-13.00
|
Round table discussion on regulatory challenges
|
||
Expert panel
·
Ana Hildago-Simon
·
Hans Ovelgönne
·
Cees de Heer
· Pauline Meij
|
Moderators:
·
Dietger
Niederwieser
· Ton Rabelink
|
||
13.00
|
End of Meeting
|
||
